Last update 25 Sep 2025

Glioma-associated antigen peptide-pulsed autologous dendritic cell vaccine(Jonsson Comprehensive Cancer Center)

Overview

Basic Info

Drug Type
Therapeutic vaccine, Dendritic cell vaccine
Synonyms-
Target-
Action-
Mechanism-
Therapeutic Areas
NeoplasmsNervous System DiseasesOther Diseases
Active Indication-
Inactive Indication
Glioblastoma MultiformeMixed oligoastrocytomaOligodendroglioma
Originator Organization
Jonsson Comprehensive Cancer Center
Active Organization-
Inactive Organization
Jonsson Comprehensive Cancer Center
License Organization-
Drug Highest PhasePendingPhase 1
First Approval Date-
Regulation-

Related

1
Clinical Trials associated with Glioma-associated antigen peptide-pulsed autologous dendritic cell vaccine(Jonsson Comprehensive Cancer Center)
NCT00612001
/ CompletedPhase 1IIT
Phase I Study of Glioma-Associated Antigen (GAA) Peptide-pulsed Dendritic Cell Vaccination in Malignant Glioma Patients
100 Clinical Results associated with Glioma-associated antigen peptide-pulsed autologous dendritic cell vaccine(Jonsson Comprehensive Cancer Center)
Login to view more data
100 Translational Medicine associated with Glioma-associated antigen peptide-pulsed autologous dendritic cell vaccine(Jonsson Comprehensive Cancer Center)
Login to view more data
100 Patents (Medical) associated with Glioma-associated antigen peptide-pulsed autologous dendritic cell vaccine(Jonsson Comprehensive Cancer Center)
Login to view more data
100 Deals associated with Glioma-associated antigen peptide-pulsed autologous dendritic cell vaccine(Jonsson Comprehensive Cancer Center)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Glioblastoma MultiformePhase 1
United States
Jonsson Comprehensive Cancer Center
01 May 2006
Mixed oligoastrocytomaPhase 1
United States
Jonsson Comprehensive Cancer Center
01 May 2006
OligodendrogliomaPhase 1
United States
Jonsson Comprehensive Cancer Center
01 May 2006
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free